Sarcoid-related uveitis occurring during adalimumab therapy

Ocular Immunology and Inflammation

Volumn 20, Issue 1, 2012, Pages 59-60

  Seve, Pascal ^a,b   Varron, Loig ^a,b   Broussolle, Christiane ^a,b   Denis, Philippe ^a,b   Kodjikian, Laurent ^a,b  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Adalimumab; Anti TNF; Sarcoidosis; Uveitis

Indexed keywords

ADALIMUMAB; FLUORESCEIN; GOLD; INDOCYANINE GREEN; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CHOROIDITIS; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; GRANULOMA; HUMAN; HUMAN TISSUE; INDOCYANINE GREEN ANGIOGRAPHY; LABORATORY TEST; OPHTHALMOSCOPY; RHEUMATOID ARTHRITIS; SARCOID UVEITIS; TREATMENT RESPONSE; UVEITIS; VASCULITIS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OPHTHALMOSCOPY; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS, POSTERIOR;

EID: 84856937730     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.623213     Document Type: Article

References (7)

1. Daien CI, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford). 2009;48:883-886.
2. Toussirot E, Pertuiset E. [TNFalpha blocking agents and sar-coidosis: an update]. Rev Med Interne. 2010;31:828-837.
3. Moller DR. Treatment of sarcoidosis-from a basic science point of view. J Intern Med. 2003,253:31-40. (Pubitemid 36120995)
4. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infiximab. Chest. 2005;127:1064-1071.
5. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum. 2007;56:3248-3252. (Pubitemid 47585419)
6. Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with anti-tumor necrosis factor agents infiximab and etanercept. Arthritis Rheum. 2005;52:2447-2451. (Pubitemid 41117431)
7. Massara A, Cavazzini L, La Corte R, Trotta F. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum. 2009;39:313-319.